Scientific jobs
Scientific jobs
As a scientific officer at EMA, you will typically be responsible for activities related to human or veterinary medicines in areas such as procedure and scientific management, scientific committee support, pharmacovigilance, and inspections and quality.
You will have obtained a degree in a science field and have proven work experience in the field of medicines regulation from the pharmaceutical industry, a national competent authority or academia. You will have knowledge and understanding of scientific aspects of medicines development, clinical trials methodology, signal detection and pharmacoepidemiology. You will be a curious, solution-driven team player who can communicate verbally and in writing with various audiences.
Title | Deadline for application | Type of position |
---|---|---|
Collaborating Expert on the application of VR/AR for learning and competence development
29 September 2024 23:59 CEST
Expert
|
||
Medicines and Medical Devices Shortages Specialist
Extended until 12 September 2024 at 23:59 CET
Temporary agent
|
||
SNE/Scientific Specialist (science & regulation)
30 September 2024 at 23:59 CEST
Seconded National Expert
|
||
Trainee (Monitoring of antimicrobial consumption and resistance)
30 September 2024 23:59 CET
Trainee
|
||
Trainee (Scientific Evidence Generation: Cooperation between regulators and HTA)
30 September 2024 23:59 CET
Trainee
|
||
Trainee (Translational sciences: Implementing the '3Rs' in medicines development and regulation)
30 September 2024 23:59 CET
Trainee
|
Regulatory Science to 2025 - Shaping the future
As science and technology advance and bring potential new treatments and diagnostic tools, regulatory science must advance in tandem so that these can be correctly, rigorously and efficiently assessed. Examples of the transformational research that is having a significant impact on the regulatory science agenda include cell-based therapies, genomics-based diagnostics, drug-device combinations, novel clinical trial design, predictive toxicology, real-world evidence, and ‘big data’ and artificial intelligence.